• Shareholders approve merger with Chemist Warehouse
• All resolutions passed with strong support
• Next steps include Court approval and scheme implementation

Sigma Healthcare Limited (Sigma) has announced that all resolutions put to its extraordinary general meeting (General Meeting) regarding the proposed merger with CW Group Holdings Limited (Chemist Warehouse) were passed. The merger is to be implemented via a scheme of arrangement under which Sigma will acquire 100% of the issued shares in Chemist Warehouse. The voting results show strong shareholder support, with all resolutions receiving over 90% of votes cast in favor. This includes approval for the significant change, placement capacity, related party arrangements, financial assistance, director elections, and changes to Sigma's performance rights and director fee pool. The next steps are for the Scheme to be approved by the Court at the Second Court Hearing scheduled for 3 February 2025. If approved, the Scheme is expected to be implemented on 12 February 2025, with Chemist Warehouse shareholders receiving the Scheme Consideration on that date. The new Sigma shares issued under the Scheme are expected to commence trading on 13 February 2025.